MegaPro Biomedical Co (ROCO:6827) Total Assets: NT$278.92 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6827 MegaPro Biomedical Co Ltd ROCO:6827
33 GF Score
Price NT$10.70
View Full Analysis

What is MegaPro Biomedical Co Total Assets?

MegaPro Biomedical Co ROCO:6827 -2.28% 33 Total Assets is NT$278.92 Mil as of Dec. 2025. GuruFocus rates ROCO:6827 with a GF Score™ of 33/100.

MegaPro Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 was NT$278.92 Mil.

During the past 12 months, MegaPro Biomedical Co's average Total Assets Growth Rate was 22.00% per year. During the past 3 years, the average Total Assets Growth Rate was -5.70% per year. During the past 5 years, the average Total Assets Growth Rate was -6.20% per year.

During the past 8 years, MegaPro Biomedical Co's highest 3-Year average Total Assets Growth Rate was -0.50%. The lowest was -19.80%. And the median was -14.50%.

Total Assets is connected with ROA %. MegaPro Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 was -47.29%. Total Assets is also linked to Revenue through Asset Turnover. MegaPro Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

MegaPro Biomedical Co  (ROCO:6827) Total Assets Explanation

Total Assets is connected with ROA %.

MegaPro Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-104.332/( (162.363+278.917)/ 2 )
=-104.332/220.64
=-47.29 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

MegaPro Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (162.363+278.917)/ 2 )
=0/220.64
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

MegaPro Biomedical Co Total Assets Related Terms

MegaPro Biomedical Co Total Assets Historical Data

* Premium members only.

The historical data trend for MegaPro Biomedical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MegaPro Biomedical Co Total Assets Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 432.61 342.68 294.58 224.32 278.92

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 294.58 306.38 224.32 162.36 278.92
ROCO:6827
33GF Score
MegaPro Biomedical Co Ltd ROCO:6827
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MegaPro Biomedical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

MegaPro Biomedical Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=262.638+16.279
=278.92

MegaPro Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=262.638+16.279
=278.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$278.92 Mil mean?
MegaPro Biomedical Co (ROCO:6827) has a Total Assets of NT$278.92 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on MegaPro Biomedical Co and its competitors.
Is MegaPro Biomedical Co's Total Assets too high?
MegaPro Biomedical Co's current Total Assets is NT$278.92 Mil. Overall, MegaPro Biomedical Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does MegaPro Biomedical Co's Total Assets compare to VRTX and REGN?
MegaPro Biomedical Co's Total Assets of NT$278.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on MegaPro Biomedical Co and its competitors. MegaPro Biomedical Co's current Total Assets is NT$278.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MegaPro Biomedical Co stock overvalued right now?
MegaPro Biomedical Co (ROCO:6827) has a current Total Assets of NT$278.92 Mil. The current Total Assets is NT$278.92 Mil. MegaPro Biomedical Co's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For MegaPro Biomedical Co (ROCO:6827), the current Total Assets is NT$278.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MegaPro Biomedical Co Business Description

Address No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
33GF Score

Get the complete analysis for ROCO:6827

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.70
Price